Vir Biotechnology, Inc.2024财年实现净利润-5.22亿美元,同比增加15.12%

市场透视
03 Mar

3月3日,Vir Biotechnology, Inc.(VIR.US)公布财报,公告显示公司2024财年净利润为-5.22亿美元,同比增加15.12%;其中营业收入为74.21百万美元,同比减少13.89%,每股基本收益为-3.83美元。从资产负债表来看,Vir Biotechnology, Inc.(VIR.US)总负债2.73亿美元,其中短期债务7.75百万美元,资产负债比为5.22,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10